Cargando…

Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates

The aggregation of proteins is considered to be the main cause of several neurodegenerative diseases. Despite much progress in amyloid research, the process of fibrillization is still not fully understood, which is one of the main reasons why there are still very few effective treatments available....

Descripción completa

Detalles Bibliográficos
Autores principales: Ziaunys, Mantas, Sakalauskas, Andrius, Mikalauskaite, Kamile, Smirnovas, Vytautas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881721/
https://www.ncbi.nlm.nih.gov/pubmed/33614299
http://dx.doi.org/10.7717/peerj.10918
_version_ 1783650937165840384
author Ziaunys, Mantas
Sakalauskas, Andrius
Mikalauskaite, Kamile
Smirnovas, Vytautas
author_facet Ziaunys, Mantas
Sakalauskas, Andrius
Mikalauskaite, Kamile
Smirnovas, Vytautas
author_sort Ziaunys, Mantas
collection PubMed
description The aggregation of proteins is considered to be the main cause of several neurodegenerative diseases. Despite much progress in amyloid research, the process of fibrillization is still not fully understood, which is one of the main reasons why there are still very few effective treatments available. When the aggregation of insulin, a model amyloidogenic protein, is tracked using thioflavin-T (ThT), an amyloid specific dye, there is an anomalous occurrence of double-sigmoidal aggregation kinetics. Such an event is likely related to the formation of ThT-positive intermediates, which may affect the outcome of both aggregation kinetic data, as well as final fibril structure. In this work we explore insulin fibrillization under conditions, where both normal and double-sigmoidal kinetics are observed and show that, despite their dye-binding properties and random occurrence, the ThT-positive intermediates do not significantly alter the overall aggregation process.
format Online
Article
Text
id pubmed-7881721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-78817212021-02-18 Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates Ziaunys, Mantas Sakalauskas, Andrius Mikalauskaite, Kamile Smirnovas, Vytautas PeerJ Biochemistry The aggregation of proteins is considered to be the main cause of several neurodegenerative diseases. Despite much progress in amyloid research, the process of fibrillization is still not fully understood, which is one of the main reasons why there are still very few effective treatments available. When the aggregation of insulin, a model amyloidogenic protein, is tracked using thioflavin-T (ThT), an amyloid specific dye, there is an anomalous occurrence of double-sigmoidal aggregation kinetics. Such an event is likely related to the formation of ThT-positive intermediates, which may affect the outcome of both aggregation kinetic data, as well as final fibril structure. In this work we explore insulin fibrillization under conditions, where both normal and double-sigmoidal kinetics are observed and show that, despite their dye-binding properties and random occurrence, the ThT-positive intermediates do not significantly alter the overall aggregation process. PeerJ Inc. 2021-02-10 /pmc/articles/PMC7881721/ /pubmed/33614299 http://dx.doi.org/10.7717/peerj.10918 Text en ©2021 Ziaunys et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Biochemistry
Ziaunys, Mantas
Sakalauskas, Andrius
Mikalauskaite, Kamile
Smirnovas, Vytautas
Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates
title Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates
title_full Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates
title_fullStr Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates
title_full_unstemmed Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates
title_short Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates
title_sort exploring the occurrence of thioflavin-t-positive insulin amyloid aggregation intermediates
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881721/
https://www.ncbi.nlm.nih.gov/pubmed/33614299
http://dx.doi.org/10.7717/peerj.10918
work_keys_str_mv AT ziaunysmantas exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates
AT sakalauskasandrius exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates
AT mikalauskaitekamile exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates
AT smirnovasvytautas exploringtheoccurrenceofthioflavintpositiveinsulinamyloidaggregationintermediates